NO20064981L - Oksadiazolonderivater som PPAR delta agonister - Google Patents

Oksadiazolonderivater som PPAR delta agonister

Info

Publication number: NO20064981L
Authority: NO; Norway
Prior art keywords: disorders; ppar; agonists; participate; compounds
Prior art date: 2004-04-01

Application number

NO20064981A

Other languages

English (en)

Norwegian (no)

Inventor

Corinne Terrier

Baptiste Ronan

Stefanie Keil

Jean Merrill

Karen Chandross

Jochen Goerlitzer

Wolfgang Wendler

Daniel G Mcgarry

Maike Glien

Patrick Bernardelli

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-01

Filing date

2006-10-31

Publication date

2006-12-28

2006-10-31 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2006-12-28 Publication of NO20064981L publication Critical patent/NO20064981L/no

Links

102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title abstract 2
108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title abstract 2
ZVTQYRVARPYRRE-UHFFFAOYSA-N oxadiazol-4-one Chemical class O=C1CON=N1 ZVTQYRVARPYRRE-UHFFFAOYSA-N 0.000 title abstract 2
239000000556 agonist Substances 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
208000035475 disorder Diseases 0.000 abstract 3
208000012902 Nervous system disease Diseases 0.000 abstract 2
208000025966 Neurological disease Diseases 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
208000016192 Demyelinating disease Diseases 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
206010022489 Insulin Resistance Diseases 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000004129 fatty acid metabolism Effects 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
201000001119 neuropathy Diseases 0.000 abstract 1
230000007823 neuropathy Effects 0.000 abstract 1
210000001428 peripheral nervous system Anatomy 0.000 abstract 1
208000027232 peripheral nervous system disease Diseases 0.000 abstract 1
208000033808 peripheral neuropathy Diseases 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20064981A 2004-04-01 2006-10-31 Oksadiazolonderivater som PPAR delta agonister NO20064981L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04007879A EP1586573B1 (en)	2004-04-01	2004-04-01	Oxadiazolones, processes for their preparation and their use as pharmaceuticals
PCT/EP2005/002950 WO2005097786A1 (en)	2004-04-01	2005-03-19	Oxadiazolone derivatives as ppar delta agonists

Publications (1)

Publication Number	Publication Date
NO20064981L true NO20064981L (no)	2006-12-28

Family

ID=34924545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064981A NO20064981L (no)	2004-04-01	2006-10-31	Oksadiazolonderivater som PPAR delta agonister

Country Status (37)

Country	Link
US (3)	US20070179191A1 (sr)
EP (3)	EP1586573B1 (sr)
JP (1)	JP2007530612A (sr)
KR (1)	KR20060135857A (sr)
CN (1)	CN100582104C (sr)
AR (1)	AR050576A1 (sr)
AT (1)	ATE435225T1 (sr)
AU (1)	AU2005231916A1 (sr)
BR (1)	BRPI0509517A (sr)
CA (1)	CA2561627A1 (sr)
CR (1)	CR8572A (sr)
CY (1)	CY1109370T1 (sr)
DE (2)	DE602004004631D1 (sr)
DK (1)	DK1740583T3 (sr)
DO (1)	DOP2005000051A (sr)
EC (1)	ECSP066892A (sr)
ES (1)	ES2329484T3 (sr)
GT (1)	GT200500028A (sr)
HR (1)	HRP20090493T1 (sr)
IL (1)	IL178056A0 (sr)
MA (1)	MA28495B1 (sr)
MY (1)	MY142431A (sr)
NO (1)	NO20064981L (sr)
PA (1)	PA8628701A1 (sr)
PE (1)	PE20060323A1 (sr)
PL (1)	PL1740583T3 (sr)
PT (1)	PT1740583E (sr)
RS (1)	RS51186B (sr)
RU (1)	RU2374243C2 (sr)
SI (1)	SI1740583T1 (sr)
SV (1)	SV2006002071A (sr)
TN (1)	TNSN06317A1 (sr)
TW (1)	TW200602342A (sr)
UA (1)	UA84203C2 (sr)
UY (1)	UY28837A1 (sr)
WO (1)	WO2005097786A1 (sr)
ZA (1)	ZA200606870B (sr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20060017929A (ko) *	2004-08-04	2006-02-28	동화약품공업주식회사	티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물
JP2009509988A (ja)	2005-09-29	2009-03-12	サノフィ−アベンティス	フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用
AU2006299092A1 (en) *	2005-09-29	2007-04-12	Sanofi-Aventis	Phenyl-(1,2,4)-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
CN101277953A (zh)	2005-09-29	2008-10-01	塞诺菲-安万特股份有限公司	2－氨基噻唑类和2－氨基唑类衍生物、它们的制备方法及它们作为药物的用途
ES2399147T3 (es)	2006-09-08	2013-03-26	Rhode Island Hospital	Tratamiento, prevención y reversión de una enfermedad hepática alcohólica
US9308198B2 (en)	2006-09-08	2016-04-12	Rhode Island Hospital	Treatment, prevention, and reversal of alcohol-induced brain disease
EP1932843A1 (en)	2006-12-14	2008-06-18	sanofi-aventis	Sulfonyl-phenyl-2H-(1,2,4) oxadiazole-5-one derivatives, processes for their preparation and their use as pharmaceuticals
US8329725B2 (en)	2008-06-09	2012-12-11	Sanofi	Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
US8716317B2 (en)	2008-06-09	2014-05-06	Sanofi	Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
WO2009149819A1 (en) *	2008-06-09	2009-12-17	Sanofi-Aventis	Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
HRP20170357T1 (hr) *	2008-10-10	2017-05-05	Vm Discovery, Inc.	Sastavi i postupci za liječenje poremećaja zbog konzumacije alkohola, bolova i ostalih bolesti
WO2010042212A2 (en)	2008-10-10	2010-04-15	Dara Biosciences, Inc.	Methods for treating or preventing pain using spicamycin derivatives
NZ597895A (en) *	2009-08-05	2012-11-30	Daiichi Sankyo Co Ltd	Amide derivative
CA2770405C (en) *	2009-08-05	2015-03-17	Daiichi Sankyo Company, Limited	Sulfone derivative
WO2015061481A1 (en)	2013-10-23	2015-04-30	Dara Biosciences, Inc.	Methods of treating liquid tumors using compositions comprising spicamycin derivatives
WO2021092279A1 (en) *	2019-11-06	2021-05-14	Board Of Regents, The University Of Texas System	Methods for the treatment of dysmyelinating/demyelinating diseases

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5256680A (en) *	1988-11-29	1993-10-26	Warner-Lambert Company	3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents
FR2663336B1 (fr)	1990-06-18	1992-09-04	Adir	Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW222626B (sr) *	1991-07-22	1994-04-21	Pfizer
IL108634A0 (en)	1993-02-15	1994-05-30	Wellcome Found	Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
IL108633A (en)	1993-02-15	1998-07-15	Wellcome Found	History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them
US5641796A (en) *	1994-11-01	1997-06-24	Eli Lilly And Company	Oral hypoglycemic agents
JP3144624B2 (ja)	1995-06-02	2001-03-12	杏林製薬株式会社	Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
AU727775B2 (en)	1996-01-17	2000-12-21	Novo Nordisk A/S	Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
IL128332A0 (en)	1996-08-30	2000-01-31	Novo Nordisk As	GLP-1 derivatives
TW492957B (en)	1996-11-07	2002-07-01	Novartis Ag	N-substituted 2-cyanopyrrolidnes
IL127296A (en)	1996-12-31	2003-01-12	Reddy Research Foundation	Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
DE19726167B4 (de)	1997-06-20	2008-01-24	Sanofi-Aventis Deutschland Gmbh	Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
PL338013A1 (en)	1997-07-16	2000-09-25	Novo Nordisk As	Derivatives of condensed 1,2,4-thiadiazine, their production and application
CO4970713A1 (es)	1997-09-19	2000-11-07	Sanofi Synthelabo	Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
DE19823831A1 (de)	1998-05-28	1999-12-02	Probiodrug Ges Fuer Arzneim	Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
SE9801992D0 (sv)	1998-06-04	1998-06-04	Astra Ab	New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr)	1998-06-04	2004-12-20	Astra Ab	Nouveaux derives de l'acide 3-aryl propionique et analogues
US6221897B1 (en)	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19828114A1 (de)	1998-06-24	2000-01-27	Probiodrug Ges Fuer Arzneim	Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de)	1998-06-24	2000-01-05	Probiodrug Ges Fuer Arzneim	Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19845405C2 (de)	1998-10-02	2000-07-13	Aventis Pharma Gmbh	Arylsubstituierte Propanolaminderivate und deren Verwendung
GB9900416D0 (en)	1999-01-08	1999-02-24	Alizyme Therapeutics Ltd	Inhibitors
DE19916108C1 (de)	1999-04-09	2001-01-11	Aventis Pharma Gmbh	Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
JP2002542245A (ja)	1999-04-16	2002-12-10	ノボノルディスクアクティーゼルスカブ	置換イミダゾール、それらの製造および使用
EP1177176B1 (en)	1999-04-28	2006-04-19	Aventis Pharma Deutschland GmbH	Tri-aryl acid derivatives as ppar receptor ligands
NZ515086A (en)	1999-04-28	2003-10-31	Aventis Pharma Gmbh	Di-aryl acid derivatives as PPAR receptor ligands
WO2000066585A1 (en)	1999-04-30	2000-11-09	Neurogen Corporation	9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
GB9911863D0 (en)	1999-05-21	1999-07-21	Knoll Ag	Therapeutic agents
DE60029446T2 (de)	1999-06-18	2007-02-08	Merck & Co., Inc.	Arylthiazolidindione und aryloxazolidindion-derivate
GB9914977D0 (en)	1999-06-25	1999-08-25	Glaxo Group Ltd	Chemical compounds
JP2003504082A (ja)	1999-07-09	2003-02-04	コヘージョンテクノロジーズ，インコーポレイテッド	エカリンポリペプチド、エカリンをコードするポリヌクレオチド、及びその利用のための方法
BR0012752A (pt)	1999-07-29	2002-04-02	Lilly Co Eli	Benzofuril piperazinas e benzofuril homopiperazinas: agonistas de serotonina
HUP0202472A3 (en)	1999-09-01	2005-03-29	Aventis Pharma Gmbh	Sulfonyl carboxiamide derivatives, method for their production and their use as medicaments
TWI302149B (en)	1999-09-22	2008-10-21	Bristol Myers Squibb Co	Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
DK1237855T3 (da)	1999-12-03	2004-06-14	Astrazeneca Ab	Krystallinsk form af (S)-2-ethoxy-3-[4-(2-(4-methansulfonyloxyphenyl)ethoxy)phenyl]propansyre
SE9904413D0 (sv)	1999-12-03	1999-12-03	Astra Ab	Comminuted form
HU229042B1 (en)	2000-03-31	2013-07-29	Prosidion Ltd	Method for the improvement of islet signaling in diabetes mellitus and for its prevention
MXPA02010545A (es)	2000-04-25	2004-05-14	Kyorin Seiyaku Kk	Cristal estable novedoso de derivado de tiazolidinediona y proceso para producir el mismo.
AU5257401A (en)	2000-04-28	2001-11-12	Asahi Chemical Ind	Novel bicyclic compounds
DE60115227T2 (de)	2000-05-11	2006-08-24	Bristol-Myers Squibb Co.	Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
EP1289526A4 (en)	2000-05-30	2005-03-16	Merck & Co Inc	MELANOCORTIN RECEPTOR AGONISTS
TR200401029T4 (tr)	2000-06-09	2004-06-21	Aventis Pharma Deutschland Gmbh	Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
TWI243162B (en)	2000-11-10	2005-11-11	Taisho Pharmaceutical Co Ltd	Cyanopyrrolidine derivatives
HRP20030498A2 (en)	2000-12-21	2005-04-30	Aventis Pharma Deutschland Gmbh	Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
WO2002067912A2 (en)	2001-02-22	2002-09-06	Smithkline Beecham Corporation	Method for treating ppar gamma mediated diseases or conditions
DE10112768A1 (de)	2001-03-16	2002-09-19	Merck Patent Gmbh	Phenylderivate 3
GB0111523D0 (en)	2001-05-11	2001-07-04	Glaxo Group Ltd	Chemical compounds
PE20021091A1 (es)	2001-05-25	2003-02-04	Aventis Pharma Gmbh	Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
DE10154689A1 (de)	2001-11-09	2003-05-22	Probiodrug Ag	Substituierte Aminoketonverbindungen
HRP20040199A2 (en)	2001-08-31	2005-04-30	Aventis Pharma Deutschland Gmbh	Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
US7205321B2 (en) *	2001-11-15	2007-04-17	Eli Lilly And Company	Peroxisome proliferator activated receptor alpha agonists
DE10215908B4 (de)	2002-04-11	2005-08-18	Aventis Pharma Deutschland Gmbh	Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
DE10215907A1 (de)	2002-04-11	2003-11-06	Aventis Pharma Gmbh	Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
DE10225635C1 (de)	2002-06-07	2003-12-24	Aventis Pharma Gmbh	N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
EP1613608A1 (en)	2003-04-01	2006-01-11	Eli Lilly And Company	Phospholipase inhibitors
EP1615900A1 (en)	2003-04-01	2006-01-18	Eli Lilly And Company	Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
DE102004005172A1 (de)	2004-02-02	2005-08-18	Aventis Pharma Deutschland Gmbh	Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
AU2006299092A1 (en) *	2005-09-29	2007-04-12	Sanofi-Aventis	Phenyl-(1,2,4)-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals

2004
- 2004-04-01 EP EP04007879A patent/EP1586573B1/en not_active Expired - Lifetime
- 2004-04-01 DE DE602004004631T patent/DE602004004631D1/de not_active Expired - Lifetime
2005
- 2005-02-17 GT GT200500028A patent/GT200500028A/es unknown
- 2005-03-19 DK DK05716233T patent/DK1740583T3/da active
- 2005-03-19 WO PCT/EP2005/002950 patent/WO2005097786A1/en not_active Ceased
- 2005-03-19 PL PL05716233T patent/PL1740583T3/pl unknown
- 2005-03-19 DE DE602005015204T patent/DE602005015204D1/de not_active Expired - Lifetime
- 2005-03-19 RS RSP-2009/0391A patent/RS51186B/sr unknown
- 2005-03-19 EP EP09005458A patent/EP2083006A1/en not_active Withdrawn
- 2005-03-19 BR BRPI0509517-4A patent/BRPI0509517A/pt not_active IP Right Cessation
- 2005-03-19 RU RU2006138498/04A patent/RU2374243C2/ru not_active IP Right Cessation
- 2005-03-19 AU AU2005231916A patent/AU2005231916A1/en not_active Abandoned
- 2005-03-19 JP JP2007505433A patent/JP2007530612A/ja not_active Abandoned
- 2005-03-19 KR KR1020067020503A patent/KR20060135857A/ko not_active Ceased
- 2005-03-19 PT PT05716233T patent/PT1740583E/pt unknown
- 2005-03-19 AT AT05716233T patent/ATE435225T1/de not_active IP Right Cessation
- 2005-03-19 SI SI200530778T patent/SI1740583T1/sl unknown
- 2005-03-19 CN CN200580010743A patent/CN100582104C/zh not_active Expired - Fee Related
- 2005-03-19 EP EP05716233A patent/EP1740583B1/en not_active Expired - Lifetime
- 2005-03-19 CA CA002561627A patent/CA2561627A1/en not_active Abandoned
- 2005-03-19 UA UAA200611486A patent/UA84203C2/ru unknown
- 2005-03-19 ES ES05716233T patent/ES2329484T3/es not_active Expired - Lifetime
- 2005-03-19 HR HR20090493T patent/HRP20090493T1/xx unknown
- 2005-03-22 PE PE2005000323A patent/PE20060323A1/es not_active Application Discontinuation
- 2005-03-30 DO DO2005000051A patent/DOP2005000051A/es unknown
- 2005-03-30 AR ARP050101221A patent/AR050576A1/es not_active Application Discontinuation
- 2005-03-30 TW TW094109908A patent/TW200602342A/zh unknown
- 2005-03-31 MY MYPI20051461A patent/MY142431A/en unknown
- 2005-04-01 PA PA20058628701A patent/PA8628701A1/es unknown
- 2005-04-01 UY UY28837A patent/UY28837A1/es unknown
- 2005-04-01 SV SV2005002071A patent/SV2006002071A/es not_active Application Discontinuation
2006
- 2006-08-15 ZA ZA200606870A patent/ZA200606870B/en unknown
- 2006-08-24 CR CR8572A patent/CR8572A/es not_active Application Discontinuation
- 2006-09-13 IL IL178056A patent/IL178056A0/en unknown
- 2006-09-26 US US11/535,266 patent/US20070179191A1/en not_active Abandoned
- 2006-09-29 MA MA29354A patent/MA28495B1/fr unknown
- 2006-09-29 TN TNP2006000317A patent/TNSN06317A1/en unknown
- 2006-09-29 EC EC2006006892A patent/ECSP066892A/es unknown
- 2006-10-31 NO NO20064981A patent/NO20064981L/no not_active Application Discontinuation
2008
- 2008-06-05 US US12/133,405 patent/US7709509B2/en not_active Expired - Fee Related
- 2008-06-05 US US12/133,408 patent/US20080262052A1/en not_active Abandoned
2009
- 2009-09-16 CY CY20091100958T patent/CY1109370T1/el unknown

Also Published As

Publication number	Publication date
DE602004004631D1 (de)	2007-03-22
PA8628701A1 (es)	2006-11-25
HK1100408A1 (zh)	2007-09-21
MA28495B1 (fr)	2007-03-01
DK1740583T3 (da)	2009-10-19
MY142431A (en)	2010-11-30
PE20060323A1 (es)	2006-03-31
GT200500028A (es)	2006-06-09
ATE435225T1 (de)	2009-07-15
AU2005231916A1 (en)	2005-10-20
EP1740583A1 (en)	2007-01-10
JP2007530612A (ja)	2007-11-01
TW200602342A (en)	2006-01-16
US20070179191A1 (en)	2007-08-02
DE602005015204D1 (de)	2009-08-13
SI1740583T1 (sl)	2009-12-31
EP1586573B1 (en)	2007-02-07
US20080262052A1 (en)	2008-10-23
AR050576A1 (es)	2006-11-08
KR20060135857A (ko)	2006-12-29
PT1740583E (pt)	2009-09-16
HRP20090493T1 (hr)	2009-10-31
RU2006138498A (ru)	2008-05-10
EP1586573A1 (en)	2005-10-19
PL1740583T3 (pl)	2009-12-31
SV2006002071A (es)	2006-01-30
UA84203C2 (en)	2008-09-25
ES2329484T3 (es)	2009-11-26
IL178056A0 (en)	2006-12-31
EP1740583B1 (en)	2009-07-01
ECSP066892A (es)	2006-11-24
CA2561627A1 (en)	2005-10-20
DOP2005000051A (es)	2005-12-15
TNSN06317A1 (en)	2007-12-03
US7709509B2 (en)	2010-05-04
CR8572A (es)	2007-12-04
CN1938300A (zh)	2007-03-28
ZA200606870B (en)	2008-04-30
US20080255212A1 (en)	2008-10-16
CY1109370T1 (el)	2014-07-02
WO2005097786A1 (en)	2005-10-20
EP2083006A1 (en)	2009-07-29
BRPI0509517A (pt)	2007-09-11
RS51186B (sr)	2010-10-31
UY28837A1 (es)	2005-10-31
CN100582104C (zh)	2010-01-20
RU2374243C2 (ru)	2009-11-27

Legal Events

Date	Code	Title	Description
2011-10-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20092293L (no)	2009-09-08	Sulfonyl-fenyl-2H-[1,2,4]oksodiazol-5-onderivater, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytiske midler
NO20064981L (no)	2006-12-28	Oksadiazolonderivater som PPAR delta agonister
NO20081367L (no)	2008-06-13	Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika
NO20081682L (no)	2008-05-06	4-oksy-N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
Manyam et al.	2004	Effect of antiparkinson drug HP‐200 (Mucuna pruriens) on the central monoaminergic neurotransmitters
NO20081369L (no)	2008-05-28	Fenyl- og pyridinyl-1,2,4-oksadiazolonderivater, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
US10344002B2 (en)	2019-07-09	Compositions and methods for treating metabolic disorders
EP2083811B1 (en)	2016-10-26	Methods of treating down's syndrome, fragile x syndrome and autism
HRP20130406T1 (hr)	2013-06-30	Medikamenti s aktivnošä†u prema receptoru hm74a
KR20170012449A (ko)	2017-02-02	결정질 베타-d-니코틴아미드 리보시드의 제조 및 용도
WO2004113270A3 (en)	2005-03-31	Propionic acid derivatives useful in the treatment of lipid disorders
NO20085064L (no)	2009-02-06	4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
JP6977029B2 (ja)	2021-12-08	レット症候群を治療するためのプリドピジンの使用
NO20082643L (no)	2008-09-01	Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
WO2005016867A3 (en)	2005-03-31	Anthranilic acid derivatives and their use as activators of the hm74a receptor
KR100597170B1 (ko)	2006-07-05	파킨슨병 치료용 릴루졸과 레보도파 배합물
US20210000804A1 (en)	2021-01-07	Combination of ibudilast and riluzole and methods of using same
EP3820476A1 (en)	2021-05-19	Use of sgc stimulators for the treatment of mitochonrial disorders
WO2004075815A3 (de)	2004-12-29	Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US20130281401A1 (en)	2013-10-24	Combination therapy for the treatment of depression and other non-infectious diseases
EP4326268A1 (en)	2024-02-28	Treatment of cns diseases with sgc stimulators
NO20081676L (no)	2008-04-29	Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
NO20054381L (no)	2005-09-21	1,3-substituerte sykloalkylderivater med sure, som oftest heterosykliske grupper, deres fremstilling og deres anvendelse som legemiddel
NO20081368L (no)	2008-06-18	Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika
NO20054389L (no)	2005-11-03	Cyckloalkyl-substituerte alkansyrederivater, fremgangsmate for fremstilling og anvendelse derav som legemiddel